KBC Group’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-7,067
Closed -$89K 1375
2014
Q2
$89K Buy
+7,067
New +$57.4K ﹤0.01% 1220
2014
Q1
Sell
-10,229
Closed -$47K 1385
2013
Q4
$47K Hold
10,229
﹤0.01% 1231
2013
Q3
$68K Buy
+10,229
New +$240K ﹤0.01% 1132

Other funds holding RNA

KBC Group's RNA Position: Q3 2014 in Review

KBC Group sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q3 2014, closing a stake of 7,067 shares — an estimated $89K sold.

KBC Group first reported a position in RNA in Q3 2013 and held it in 3 quarters. The position peaked at $89K in Q2 2014. 32 funds tracked by Wall St. Rank hold RNA as of Q3 2014.

  • KBC Group reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q3 2014 after selling out during the quarter.
  • KBC Group sold 7,067 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q3 2014, an estimated $89K.
  • KBC Group first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 3 quarters.
  • KBC Group's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $89K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q3 2014.

Based on KBC Group's 13F filing for Q3 2014, filed 16 Oct 2014.